Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc Reaffirms FY 2013 Guidance


Thursday, 6 Jun 2013 04:30pm EDT 

Quest Diagnostics Inc announced that for fiscal 2013, it expects revenue to approximate the prior year level and earnings per diluted share (EPS) to be between $4.35 and $4.55. The Company reported revenues of $7.382 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $7.310 billion and EPS of $4.35 for fiscal 2013. 

Related Company News

Company Quote

67.94
-0.16 -0.23%
24 Dec 2014